Adicet Bio, Inc. (ACET) Dividend History

Adicet Bio, Inc. is a biotechnology company focused on the development of allogeneic cell therapies for cancer and other diseases. Leveraging innovative immune cell engineering technologies, Adicet aims to create off-the-shelf, highly effective treatments that harness the body's immune system to target and destroy disease cells.

131 Dartmouth Street, Boston, MA, 02116
Phone: 617-482-2333
Website: https://www.adicetbio.com

Dividend History

Adicet Bio, Inc. currently does not pay dividends

Company News

  • The Royal Office of H.H. Sheikh Ahmed Bin Faisal Al-Qassimi and ACET ($ACT) Drive Blockchain Payment Innovation in UAE’s $3.9 Billion USD Initiative

    ACET ($ACT), a blockchain-powered DeFi platform, has partnered with the Royal Office of H.H. Sheikh Ahmed Bin Faisal Al-Qassimi to drive blockchain adoption and financial innovation in the UAE, including integrating ACET ($ACT) into a $3.9 billion casino resort project.

    GlobeNewswire Inc.
  • Why Adicet Bio (ACET) Stock Might be a Great Pick

    Adicet Bio (ACET) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

    Zacks Investment Research
  • Why JetBlue Airways Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

    Shares of JetBlue Airways Corporation (NASDAQ: JBLU) fell sharply during Tuesday’s session. JetBlue’s President & COO Joanna Geraghty will succeed Robin Hayes as CEO, effective Feb. 12, 2024. B of A Securities analyst Andrew Didora downgrades JetBlue Airways from Neutral to Underperform and lowered the price target from $6 to $3. JetBlue Airways shares dipped 10.9% to $5.13 on Tuesday. Here are some other stocks moving in today's mid-day session. Gainers NexImmune, Inc. (NASDAQ: NEXI) shares jumped 89.2% to $14.32. Sentage Holdings Inc. (NASDAQ: SNTG) shares climbed 65.3% to $3.52. MicroCloud Hologram Inc. (NASDAQ: HOLO) gained 41.9% to $0.3450. Cutera, Inc. (NASDAQ: CUTR) surged 28.2% to $4.2150. Cutera said it expects FY23 revenue of $211.5 million to $212.5 million versus prior guidance of $205 million. Virios Therapeutics, Inc. (NASDAQ: VIRI) shares rose 28% to $0.7520. Galera Therapeutics, Inc. (NASDAQ: GRTX) jumped 26% to $0.1880. Adicet Bio, Inc. (NASDAQ: ACET) gained 26% to $3.10. NGM Biopharmaceuticals, Inc. (NASDAQ: NGM) gained 24.6% to $1.5700. NGM Bio announced clinical data from trial of NGM707 In advanced solid tumors and outlines evolved strategy for aldafermin and NGM120. Galera Therapeutics, Inc. (NASDAQ: GRTX) gained 23.5% to $0.1844. Juniper Networks, Inc. (NYSE: JNPR) rose 21.5% to $36.71. Hewlett Packard Enterprise Co (NYSE: HPE) is reportedly in advanced discussions to acquire networking equipment competitor Juniper Networks. LeddarTech Holdings Inc. (NASDAQ:

    Benzinga
    Featured Companies: ACMR AIMD AYI BOWL CENX EJH HOLO HPE ILMN JBLU JNPR JWEL KITT KORE LDTC NEOG SGD SNTG TLRY U URBN YCBD

Related Companies

Page data last updated 07/23/2025 16:59:09 UTC